- Home
- ESPR vs HWBK Comparison
ESPR vs HWBK Comparison
Compare ESPR & HWBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- HWBK
- Stock Information
- Founded
- ESPR 2008
- HWBK 1865
- Country
- ESPR United States
- HWBK United States
- Employees
- ESPR N/A
- HWBK N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- HWBK Major Banks
- Sector
- ESPR Health Care
- HWBK Finance
- Exchange
- ESPR Nasdaq
- HWBK Nasdaq
- Market Cap
- ESPR 208.1M
- HWBK 205.8M
- IPO Year
- ESPR 2013
- HWBK N/A
- Fundamental
- Price
- ESPR $0.85
- HWBK $28.82
- Analyst Decision
- ESPR Buy
- HWBK
- Analyst Count
- ESPR 7
- HWBK 0
- Target Price
- ESPR $5.93
- HWBK N/A
- AVG Volume (30 Days)
- ESPR 6.2M
- HWBK 13.1K
- Earning Date
- ESPR 05-06-2025
- HWBK 07-29-2025
- Dividend Yield
- ESPR N/A
- HWBK 2.76%
- EPS Growth
- ESPR N/A
- HWBK 816.74
- EPS
- ESPR N/A
- HWBK 2.75
- Revenue
- ESPR $259,574,000.00
- HWBK $72,980,000.00
- Revenue This Year
- ESPR $4.07
- HWBK N/A
- Revenue Next Year
- ESPR N/A
- HWBK N/A
- P/E Ratio
- ESPR N/A
- HWBK $10.50
- Revenue Growth
- ESPR 12.99
- HWBK 34.33
- 52 Week Low
- ESPR $0.69
- HWBK $18.74
- 52 Week High
- ESPR $3.94
- HWBK $35.95
- Technical
- Relative Strength Index (RSI)
- ESPR 44.65
- HWBK 44.57
- Support Level
- ESPR $0.79
- HWBK $29.13
- Resistance Level
- ESPR $0.88
- HWBK $29.99
- Average True Range (ATR)
- ESPR 0.07
- HWBK 1.15
- MACD
- ESPR 0.02
- HWBK -0.17
- Stochastic Oscillator
- ESPR 69.48
- HWBK 8.33
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About HWBK Hawthorn Bancshares Inc.
Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.